Advanced search×

Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone

Changyong C Feng, Sean S Meldrum, and Kevin K Fiscella

Int J Gynaecol Obstet 109(2):4 (2010) PMID 20132932

Objective: To examine mediators of mifepristone treatment on improvements in health-related quality of life (HRQOL) among women with symptomatic fibroids. Methods: The study sample included women with symptomatic uterine fibroids who were treated with 5mg or 2.5mg of mifepristone or placebo. Assessments of uterine size (ultrasound), pain (McGill pain questionnaire), bleeding (diary), anemia (gm/dL), and HRQOL measured using the uterine fibroid symptom quality of life scale were done at baseline, 3months, and 6months. The improvements in HRQOL that could be explained by changes in these clinical factors were assessed. Results: The final sample included 62 women. Treatment with mifepristone was associated with significant improvement in HRQOL, which was explained in part by reduction in pain (28%, P<0.001). Reduction in uterine volume was of marginal significance (P=0.05) and was associated with a decrease in HRQOL (7%). Much of the impact of treatment on HRQOL (61%) remained unexplained in this model. Conclusions: Improvements in HRQOL after treatment with mifepristone are partly explained by improvements in pain and bleeding, but not uterine size. However, most of the improvement in HRQOL is not explained by improvements in these clinical parameters.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.ijgo.2009.11.019
Version: za2963e q8za3 q8zb5 q8zc0 q8zd6 q8ze3 q8zfa q8zg3
View PDF

Similar articles you may find interesting…

  1. Disparities in Disability After Traumatic Brain Injury Among Hispanic Children and Adolescents.
    Nathalia Jimenez, Beth E Ebel, and Frederick P Rivara

    Pediatrics (2013) PMID 23650302

    Hispanic children with TBI report larger and long-term reductions in their quality of life, participation in activities, communication, and self-care abilities compared with NHW children. The reasons for these differences need to be better understood and interventions implemented to improve the outco...
  2. The therapeutic goals of essential thrombocythemia under the clouds of over-treatment and under-treatment.
    Ibrahim C Haznedaroglu

    Expert Opin Pharmacother (2013) PMID 23647225

    Therapeutic stratification after the accurate essential thrombocythemia (ET) diagnosis is made based on the medical history (age, previous thrombosis), clinical assessments (cardiovascular [CV] risk factors, comorbidities, systemic diseases), laboratory examinations (leukocytosis, extreme thrombocyt...
  3. A Randomized Clinical Trial Comparing an Acceptance-Based Behavior Therapy to Applied Relaxation for Generalized Anxiety Disorder.
    Sarah A Hayes-Skelton, Lizabeth Roemer, and Susan M Orsillo

    J Consult Clin Psychol (2013) PMID 23647281

    Mixed effect regression models showed significant, large effects for time for all primary outcome measures (ds = 1.27 to 1.61) but nonsignificant, small effects for condition and Condition × Time (ds = 0.002 to 0.20), indicating that clients in the 2 treatments improved comparably over treatment. F...